Suppr超能文献

结肠切除术是溃疡性结肠炎患者发生静脉血栓栓塞的一个危险因素。

Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.

作者信息

Kaplan Gilaad G, Lim Allen, Seow Cynthia H, Moran Gordon W, Ghosh Subrata, Leung Yvette, Debruyn Jennifer, Nguyen Geoffrey C, Hubbard James, Panaccione Remo

机构信息

Gilaad G Kaplan, Allen Lim, Cynthia H Seow, Gordon W Moran, Subrata Ghosh, Yvette Leung, James Hubbard, Remo Panaccione, Inflammatory Bowel Disease Clinic, University of Calgary, Calgary AB T2N 4N1, Canada.

出版信息

World J Gastroenterol. 2015 Jan 28;21(4):1251-60. doi: 10.3748/wjg.v21.i4.1251.

Abstract

AIM

To compare venous thromboembolism (VTE) in hospitalized ulcerative colitis (UC) patients who respond to medical management to patients requiring colectomy.

METHODS

Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by: (1) responsive to inpatient medical therapy (n=382); (2) medically refractory requiring emergent colectomy (n=309); and (3) elective colectomy (n=329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course (i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications (i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios (OR) with 95%CI.

RESULTS

The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparin prophylaxis. In contrast, VTE was higher among patients who underwent an emergent (8.7%) and elective (4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal (45.8%) followed by lower extremity (19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective (adjusted OR=3.69; 95%CI: 1.30-10.44) and emergent colectomy (adjusted OR=5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time (adjusted OR=1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE.

CONCLUSION

VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.

摘要

目的

比较接受药物治疗的住院溃疡性结肠炎(UC)患者与需要结肠切除术的患者发生静脉血栓栓塞(VTE)的情况。

方法

采用1997年至2009年基于人群的监测,确定所有因UC发作入院的成年人以及接受结肠切除术的患者。审查所有病历以确认诊断并提取临床相关信息。UC患者分为:(1)对住院药物治疗有反应者(n = 382);(2)药物治疗无效需急诊结肠切除术者(n = 309);(3)择期结肠切除术者(n = 329)。主要结局是住院期间或出院后6个月内发生VTE。评估预防VTE的肝素预防措施。逻辑回归分析在调整包括年龄、性别、吸烟、疾病活动度、合并症、疾病范围和IBD药物(即皮质类固醇、美沙拉嗪、硫唑嘌呤和英夫利昔单抗)等混杂因素后,确定疾病进程(即对药物治疗有反应、药物治疗无效和择期结肠切除术)对VTE的影响。点估计值以比值比(OR)及95%置信区间表示。

结果

对药物治疗有反应的UC患者中VTE的患病率为1.3%,其中仅16%的患者接受了肝素预防。相比之下,急诊(8.7%)和择期(4.9%)结肠切除术患者的VTE发生率更高,尽管超过90%的患者接受了术后肝素预防。VTE最常见的部位是腹腔内(45.8%),其次是下肢(19.6%)。16.7%的病例在出院后诊断出VTE。与对药物治疗有反应的UC患者相比,择期(调整后OR = 3.69;95%CI:1.30 - 10.44)和急诊结肠切除术(调整后OR = 5.28;95%CI:1.93 - 14.45)是VTE的显著危险因素。此外,VTE的发生几率随时间显著增加(调整后OR = 1.10;95%CI:1.01 - 1.20)。年龄、性别、合并症、疾病范围、疾病活动度、吸烟、皮质类固醇、美沙拉嗪、硫唑嘌呤和英夫利昔单抗与VTE的发生无独立关联。

结论

VTE与结肠切除术相关,尤其是在药物治疗无效的UC患者中。肝素预防可能不足以预防接受结肠切除术患者的VTE。

相似文献

7
Postoperative complications and mortality following colectomy for ulcerative colitis.溃疡性结肠炎结肠切除术后的并发症和死亡率。
Clin Gastroenterol Hepatol. 2011 Nov;9(11):972-80. doi: 10.1016/j.cgh.2011.07.016. Epub 2011 Jul 30.

引用本文的文献

9
Venous thromboembolism in inflammatory bowel disease.炎症性肠病中的静脉血栓栓塞症。
World J Gastroenterol. 2020 Mar 28;26(12):1231-1241. doi: 10.3748/wjg.v26.i12.1231.
10
Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups.炎症性肠病发作时的静脉血栓栓塞预防
Ann Gastroenterol. 2019 Nov-Dec;32(6):578-583. doi: 10.20524/aog.2019.0412. Epub 2019 Aug 31.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验